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Abstract
Background: Artificial intelligence (AI) is increasingly being used in healthcare. Here, AI-based chatbot systems can act as
automated conversational agents, capable of promoting health, providing education, and potentially prompting behaviour
change. Exploring the motivation to use health chatbots is required to predict uptake; however, few studies to date have
explored their acceptability. This research aimed to explore participants’ willingness to engage with AI-led health chatbots.
Methods: The study incorporated semi-structured interviews (N-29) which informed the development of an online survey
(N-216) advertised via social media. Interviews were recorded, transcribed verbatim and analysed thematically. A survey of
24 items explored demographic and attitudinal variables, including acceptability and perceived utility. The quantitative data
were analysed using binary regressions with a single categorical predictor.
Results: Three broad themes: ‘Understanding of chatbots’, ‘AI hesitancy’ and ‘Motivations for health chatbots’ were identified,
outlining concerns about accuracy, cyber-security, and the inability of AI-led services to empathise. The survey showed
moderate acceptability (67%), correlated negatively with perceived poorer IT skills OR¼ 0.32 [CI95%:0.13–0.78] and dislike
for talking to computers OR¼ 0.77 [CI95%:0.60–0.99] as well as positively correlated with perceived utility OR¼ 5.10
[CI95%:3.08–8.43], positive attitude OR¼ 2.71 [CI95%:1.77–4.16] and perceived trustworthiness OR¼ 1.92 [CI95%:1.13–3.25].
Conclusion: Most internet users would be receptive to using health chatbots, although hesitancy regarding this technology
is likely to compromise engagement. Intervention designers focusing on AI-led health chatbots need to employ user-centred
and theory-based approaches addressing patients’ concerns and optimising user experience in order to achieve the best
uptake and utilisation. Patients’ perspectives, motivation and capabilities need to be taken into account when developing
and assessing the effectiveness of health chatbots.
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Introduction
Artificial intelligence (AI) is an umbrella term for com-
puter software consisting of a complex mathematical
algorithm that processes input information to produce
any specific pre-defined outputs, which lead to relevant
outcomes.1 AI systems, which utilise large datasets, can
be designed to enhance decision-making and analytical
processes while imitating human cognitive functions.
AI has been applied in medicine and various healthcare
services such as diagnostic imaging and genetic diagno-
sis, as well as clinical laboratory, screening and health
communications.2,3 These systems aid physicians by
providing pertinent medical information in order to
reduce diagnostic or therapeutic errors, and alerts
about any high-risk health outcomes. The recent
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digitalisation of healthcare services in the UK offers
access to large pools of clinical data such as medical
notes, electronic records, physical and laboratory
examination or patient demographic and behavioural
characteristics.4 It is anticipated that by 2024, every
patient in England would have digital access to primary
care consultations, with a reduced need for face-to-face
outpatient visits. In addition, there is an ongoing trans-
formation to provide fully digitalised acute, community
and mental health services across all locations. AI sys-
tems can utilise such clinical data to enhance diagnostic
accuracy and enable clinicians to offer patient-centred
medical care, while eliminating variations across the
country and helping patients in managing their condi-
tions themselves.
Chatbots, as part of AI devices, are natural language
processing systems acting as a virtual conversational
agent mimicking human interactions.5 While this tech-
nology is still in its developmental phase, health chat-
bots could potentially increase access to healthcare,
improve doctor–patient and clinic–patient communica-
tion, or help to manage the increasing demand for
health services such as via remote testing, medication
adherence monitoring or teleconsultations.6–8 The
chatbot technology allows for such activities as specific
health surveys, setting up personal health-related
reminders, communication with clinical teams, booking
appointments, retrieving and analysing health data or
the translation of diagnostic patterns taking into
account behavioural indicators such as physical activ-
ity, sleep or nutrition.9 Such technology could poten-
tially alter the delivery of healthcare systems, increasing
uptake, equity and cost-effectiveness of health services
while narrowing the health and well-being gap,10 but
these assumptions require further research.
So far, chatbots have been applied in health educa-
tion, diagnostics and mental health. A survey of con-
versational agents from 40 articles outlines chatbot
taxonomy, specifies the main challenges and defines
the types and contexts related to chatbots in health.11
For example, chatbots can provide instant responses to
health-related enquiries from patients while looking for
specific patterns of symptoms in predicting disease, as
presented by the internet-based Doc-Bot delivered via
mobile phone or a Messenger-based chatbot for outpa-
tient and translational medicine.12 They can be tailored
to specific populations, health conditions or behav-
iours. Crutzen et al. demonstrated the high engagement
with a chatbot for adolescent students providing edu-
cation on sex, drugs and alcohol.13 The users had pos-
itive views on the chatbot with emphasis on its
anonymity as well as the quality and the speed of
receiving information in comparison to popular
search engines. The chatbot was seen as a reliable
source of information; however, the ease of use was
rated as low, indicating challenges in implementing
the technology on a larger scale. Other systems have
also been proposed to act as a symptom checker,14
online triage service15 or health promotion assistant,16
providing live feedback in an interactive way. In addi-
tion, a number of studies have shown the usability of
chatbot systems in mental health, in particular as a
novel way of developing therapeutic and preventative
interventions.17–19 For example, Ly et al. demonstrated
the effectiveness of a chatbot based on cognitive behav-
ioural therapy and positive psychology interactions in
the non-clinical population.20 There was a significant
impact on well-being and perceived stress, with some
participants reporting a specific ‘digital relationship’
with the chatbot. Nevertheless, chatbot systems are typ-
ically designed for specific functions, mainly to provide
information. One of the main criticisms of chatbots is
that they are not capable of empathy, notably to recog-
nise users’ emotional states and tailor responses reflect-
ing these emotions. The lack of empathy may therefore
compromise the engagement with health chatbots.21
There is little research on health chatbot acceptability
and motivations for its use. The acceptability of a health-
care intervention is a multi-faceted construct based on a
range of dimensions including burden, values, effective-
ness, cognition, and emotional responses.22 A study of
100 physicians in the US concluded that although the
majority believed chatbots could assist with scheduling
doctors’ appointments, locating health clinics and pro-
viding information about medication, over 70% also
thought they cannot care for all patients’ needs, display
emotion and could be a risk to patients due to incorrect
self-diagnosis.23 As these digital systems are capable of
enhancing patient experiences of healthcare, and poten-
tially influencing health behaviours, a theory-driven and
person-centred approach is needed to inform their devel-
opment and implementation. This study aimed to
explore the acceptability of AI-led health chatbots to
identify possible barriers and facilitators that could influ-
ence the delivery of these novel services. The findings are




We used a mixed-methods approach24 to assist in cre-
ative knowledge generation of a multi-layered issue.25
Specifically, we incorporated face-to-face semi-struc-
tured interviews and an online survey format to explore
the motivations for the use of chatbots in healthcare.
Our interviews were guided by a topic schedule and
informed the development of the exploratory survey
distributed on social media. The study was approved
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by the University of Southampton Ethics Committee
(ref: 30986/31719).
Recruitment and data collection
Between November 2017 and January 2018, paper and
digital adverts were distributed around the University
of Southampton campus inviting students to take part
in individual interviews in order to assess the attitudes
towards new technologies in healthcare. Potential par-
ticipants were asked to email researchers to arrange a
suitable time and place for the interview. They were no
specific exclusion criteria, although participants needed
to be above the age of 18 years and capable of consent-
ing to the study. There was no focus on any particular
population in relation to healthcare utilisation, and this
qualitative component of the study aimed to explore
general views on health chatbots. As the advertisement
strategy concentrated around the university settings, it
was assumed that most participants had been familiar
with conventional digital technologies.
The qualitative arm of the study was guided by a
topic schedule, which was based on the theoretical
framework of healthcare intervention acceptability22
that was adopted for health chatbots. The schedule
consisted of five sets of open-ended questions exploring
the understanding of chatbots, attitudes, usability and
general concerns. The semi-structured interviews took
place in a room at the University of Southampton.
The interviews were conducted by two trained
researchers who were also involved in transcription,
analysis and data validation. All participants were
asked to sign a consent form and were reminded about
their rights for confidentiality and that they could with-
draw from the study at any time without penalty. It was
assumed that many participants had not experienced
using a chatbot in the past; thus a chatbot demonstration
was performed during the interview. The participants
were asked to conduct a live conversation with a popular
chatbot26 in order to gather more credible views on chat-
bot acceptability. The interaction allowed participants to
post any questions for the chatbot and gain immediate
answers. The interviews lasted 20–30 minutes, were
audio-recorded and transcribed verbatim. No incentive
was offered to participants.
Between February and June 2018, an advert for the
online survey was distributed on social media pages
(i.e. university accounts on Facebook, Twitter and
eFolio such as student union) inviting users to com-
plete a short questionnaire about health chatbots. No
particular health-specific pages were targeted for the
advertisement; however, this quantitative arm of the
study used a digital snowball sampling method encour-
aging users to share the study advert on their social
media profiles. This method is likely to represent
views of the internet users more familiar with social
media, although no specific populations were targeted.
The participation was voluntary, and the respondents
were offered a chance to enter a prize draw worth £50.
The internet users were directed to the survey after
clicking on a pre-designed online advert. They were
shown information about the study and asked to pro-
vide online consent by ticking a box. The survey took
about 10 minutes to complete. The online survey con-
sisted of 24 items, both demographic and attitudinal. It
was developed based on the theoretical framework of
acceptability22 and the findings from the qualitative
interviews. The participants were asked general ques-
tions about the awareness and experience of chatbots,
and more specifically about health chatbots. They were
then presented with two sets of questions examining the
perceived usefulness of health chatbots and their gen-
eral attitudes. The perceived usefulness questions,
assessed using a 5-point Likert scale (from ‘extremely
unlikely’ to ‘extremely likely’), asked participants to
rate their willingness to use chatbots for seeking gener-
al health information, information about medication,
various diseases, potential symptoms, seeking results of
medical tests, booking a medical appointment and
looking for specialist medical services. The attitudinal
questions, assessed using a 5-point Likert scale (from
‘strongly disagree’ to ‘strongly agree’), asked partici-
pants to indicate their agreement with 16 statements
about their healthcare such as the worry about digital
privacy, the accuracy of health information online, the
preference for face-to-face interaction and trust in
advice from a health chatbot. The main outcome mea-
sure – health chatbot acceptability – was assessed using
one question: ‘How likely would you be to use a health
chatbot in the next 12 months if it was available to you
today?’ with five options (from ‘extremely unlikely’ to
‘extremely likely’).
Data analysis
Thematic analysis27 was conducted on qualitative data
to identify common patterns and trends. Two research-
ers familiarised themselves with the data by repeatedly
reading the transcript to enhance understanding. The
analyses were conducted independently using NVIVO
software where data were coded and recorded to then
be categorised into meaningful themes and subthemes.
The results of the analysis were discussed between the
researchers to find an agreement for the final set of find-
ings. The themes were then validated by two researchers
comparing quotes with the identified themes.
Descriptive and inferential statistics were conducted
on quantitative data. All variables were dichotomised,
and neutral values excluded in order to perform binary
logistic regressions with a single categorical predictor
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to determine the correlates of health chatbot accept-
ability. The model was not adjusted as it did not
meet the statistical assumptions, due to multicollinear-
ity and non-binominal distribution of responses.
However, the regression allowed assessing the corre-
lates of chatbot acceptability and their directions.
The odds ratio and 95% confidence intervals were
presented as the magnitude of association with the
outcome variable in an explorative manner.
Results
Sample characteristics
In our qualitative sub-study, 29 participants (all uni-
versity students, 24 self-identified as White and 15 as
women) aged 18–22 years were interviewed. In our
quantitative sub-study, 215 users completed the
survey. The mean age was 30 years (SD¼ 12, range:
18–62) and the majority were women (61%), of
White ethnicity (64%) and educated below the univer-
sity degree (54%). Most (76%) rated their IT skills as
‘good’ or ‘very good’, and many reported looking for
medical information online a few times per year (41%)
or every month (33%).
Qualitative analysis
Qualitative data were organised into three themes:
‘Understanding of chatbots’, ‘AI Hesitancy’ and
‘Motivations for health chatbot’. Table 1 presents all
themes and subthemes with corresponding quotes.
Understanding of chatbots
Most participants reported hearing about bots, notably
in the context of social media or customer service, but
were unsure how they functioned technologically. Due
to limited experience with chatbots, the majority were
unable to recall if they ever used one for their health-
care. After the chatbot demonstration, the participants
appreciated the mainstream chatbot systems available,
such as Alexa or Google Home, in particular in relation
to information searches. However, they agreed that this
technology was still emergent, and not part of the
mainstream culture, despite large media coverage
about AI. There was a general lack of familiarity and
understanding of health chatbots amongst participants.
AI hesitancy
Many participants were hesitant about whether they
would incorporate chatbots as part of their healthcare.
They were uncertain about the quality, trustworthiness
and accuracy of the health information provided by
chatbots, as the sources underpinning such services
were not transparent. The majority of participants
reported not being able to understand the technological
complexity of chatbots, in particular how they are able
to correctly respond to a health enquiry. There was a
doubt about whether a chatbot could correctly identify
symptoms of less common health conditions or dis-
eases. A number of participants emphasised the poten-
tial for miscommunication between a chatbot and its
users, who might not be able to accurately describe
their health issues or name symptoms. There was a
perception of a risk of harm if the information provid-
ed by a chatbot was inaccurate or inadequate. In gen-
eral, there was a view that this technology was
premature in terms of providing a diagnosis, as it was
seen as an ‘unqualified’. However, most participants
found receiving general health advice acceptable.
While a few participants thought that well-designed
chatbots can be more accurate and logical compared
with doctors, the lack of human presence was seen as
the main limitation. In particular, participants worried
about a lack of empathy and inability of chatbots to
understand more emotional issues, notably in mental
health. The responses given by chatbots were seen as
depersonalised, cold and inhuman. They were per-
ceived as inferior to doctor consultation, although sev-
eral participants admitted that this technology offered
a level of anonymity which could facilitate the disclo-
sure of more intimate or uncomfortable aspects to do
with health. Other participants were concerned about
cyber-security and the ability (or not) of chatbots to
maintain confidentiality so that their sensitive health-
related information was protected from potential hack-
ing or data leakage. There was also a concern that
health chatbots could reduce the overall quality of
healthcare if they were to replace experienced trained
professionals.
Motivations for health chatbots
The majority of participants were willing to use chat-
bots for minor health concerns that would not require a
physical examination. They were perceived as a conve-
nient tool that could facilitate the seeking of health
information online. Several participants compared
chatbots to medical phone helplines, such as NHS
Direct, that provide rapid guidance and health advice
on minor health issues. They perceived chatbots to be
particularly useful when they might struggle to compre-
hend the advice given via telephone, seeing written
information as easier to understand. Some expressed
preferences for a web-chat format of conversation.
Thus, if free at the point of access, chatbots were
seen as time-saving and useful platforms for triaging
users to appropriate healthcare services.
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(Awareness) “I think that it’s online and you ask it questions and it can reply to you with information. It is not a real person. It
is like stored information.”
“There are those diagnosis bots and you can use. Those to get an idea of what is wrong with you or what your
next step could be if it can just tell you a rough severity of what you may have. Then I suppose it is useful in
those cases but, in terms of just chatting to something and telling it your problems or whatever and trying to
get a diagnosis. If you are using it in that kind of way then I think that is a very limited thing to try and do.”
“I’ve used one for banking before, and you just type in your query. And I think I’ve used some which you type to
and it picks out keywords, and one which you can select the most appropriate response.”





“It’s not that I think they [chatbots] would intentionally give me false information. I just don’t know how accurate
they are. I don’t know whether they can be as accurate as doctors can be.”




“I think it has a lot of potential in the future, but now certain places are releasing it before they have perfected
their own system, then it could put people off. Because you can end up chatting for like half an hour and go
back to being at the same question you were at in the first place. With that people get angry.”
“I don’t know whether the technology is as adequate as a doctor.”
(Non-human
interaction)
“I think a lot of people would be put off just being with a chatbot. It is like a segregation thing, I don’t think it will
replace human interaction.”
“If you are looking at a chatbot thinking that it is a replacement for a person then you are looking it in the wrong
way. If you were looking for a deep and meaningful conversation you are not going to find one.”
(Cyber-
security)
“Some people might find issues with confidentiality because if you were with the doctor it is just you and them,
but with chatbots, you don’t know who is behind it all.”
“Some things are confidential and you wouldn’t just type it on the internet. You would want the confidentiality of
the GP practice.”
Motivations for health chatbots
(Anonymity) “I think for mental health it would be pretty useful because I think that it’s a lot harder to talk to a real person about
that. Maybe sexual health too. I’m pretty open generally about both of those things but I can see where they might
be seen as a better alternative due to privacy and not having to face a person and describe all of these problems.”
“I think mental health would be a good thing to use a chatbot in, because some people with mental health issues
they do not want to open up to an actual person, so it would be easier doing it over the internet in the comfort of
their own home.”
(Convenience) “You can use a chatbot instead of googling it and reading advice on the NHS page. If that information is
integrated into the chatbot then yeah it would certainly save time.”
“It would be good for healthcare because obviously, it is so hard to get a doctor’s appointment, so for people who
have general queries like it would be good for them to quickly get advice on whether or not it is an urgent issue.”
(Sign-posting) “Chatbot can tell you if you need further advice or you will worry. And it will reassure you so you don’t go to the
doctors.”
“People who have no awareness of or are perhaps too worried, it could be a good way to get in touch. Just like if
you use 111, first of all, you go to a chatbot and they would figure out what is wrong and if there was a
severity to it they would ring 999 and get an ambulance, otherwise, they can direct you to a GP and a clinic.”
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Quantitative analysis
Table 2 presents sample characteristics and correlates of
health chatbot acceptability amongst 215 participants.
The analysis showed that while 6%had heard of a health
chatbot and 3% had experience of using it, 67% per-
ceived themselves as likely to use one within 12
months. None of the demographic variables was associ-
ated with acceptability, although those who perceived
themselves to have poor or moderate IT skills showed
lower acceptability. The majority of participants would
use a health chatbot for seeking general health informa-
tion (78%), booking a medical appointment (78%) and
looking for local health services (80%). However, a
health chatbot was perceived as less suitable for seeking
results of medical tests and seeking specialist advice such
as sexual health. All nine itemsmeasuring perceived util-
ity were associated with chatbot acceptability with the
highest levels reported for seeking general health infor-
mation as well as the information about symptoms and
medication. The analysis of attitudinal variables showed
that most participants reported their preference for dis-
cussing their health with doctors (73%) and having
access to reliable and accurate health information
(93%). While 80%were curious about new technologies
that could improve their health, 66% reported only
seeking a doctor when experiencing a health problem
and 65% thought that a chatbot was a good idea.
Interestingly, 30% reported dislike about talking to
computers, 41% felt it would be strange to discuss
health matters with a chatbot and about half were
unsure if they could trust the advice given by a chatbot.
Nine attitudinal items were associated with acceptabili-
ty, with perceived trust and the belief that a chatbot was
a good idea being the strongest predictors.
Discussion
To our knowledge, this is the first study exploring
the acceptability of AI-led chatbot systems for health-
care from the perspective of the general public with no
pre-existing medical conditions. The awareness and
experience of health chatbots were low amongst our
participants, and most had mixed attitudes towards
these novel technologies. The qualitative analysis
showed that a substantial proportion was hesitant to
AI and health chatbots, mainly because of concerns
about the accuracy and security of these services.
There was also a view that chatbots could enable some
users to discuss their intimate and perhaps embarrassing
health issues, promoting access to professional health
services. Although they were seen as a convenient and
anonymous tool for minor health issues that may carry a
level of stigma, the lack of empathy and professional
human approach made chatbots less acceptable to
some users. The survey demonstrated that the partici-
pants were more willing to use these systems to find gen-
eral health information over finding out the results of
medical tests or specialist advice. Amongst the strongest
predictors of acceptability were positive attitudes
towards health chatbots and the curiosity about new
technologies that could improve health. Also, those
who showed dislike for talking to chatbots and preferred
to discuss their health face-to-face with a clinician were
less likely to accept chatbots. Although these innovative
services were acceptable by the majority of participants,
we propose that ‘AI hesitancy’ would have a negative
influence on the engagement and effectiveness of those
technologies. Therefore, the patient perspective needs to
be taken into consideration when developing AI-
enabled health services.
These findings are consistent with previous research
and theoretical frameworks on the acceptability of
novel health interventions. The acceptability rate in
the present study is comparable to the acceptability
level of 49% within a Dutch cohort offered use of a
chatbot for smoking cessation.16 Nevertheless, Laufer
has already argued that the social acceptability of AI
systems is compromised by the ambiguous status of
‘artificial’, which has negative and ‘inferior-to-natural’
connotations.28 According to the Diffusion of
Innovation theories, the implementation of new tech-
nologies is a process in which the adoption is depen-
dent on widespread awareness, understanding and
utilisation.29 Adopters are generally divided into inno-
vators, early adopters, majority users and laggards.
While the passage of time is necessary for any innova-
tion to be adopted, certain characteristics of social sys-
tems such as governmental endorsement, mass media
campaigns or personal views of social role models are
likely to influence potential adopters. The theoretical
framework of acceptability22 outlines that the burden
of engaging with the intervention, ethical consequences
and negative user experiences are likely to increase hes-
itancy or even lead to the failure of the intervention.
Hence, the concerns about accuracy, trustworthiness
and privacy, as well as the perceived lack of empathy,
are likely to compromise the adoption of AI systems in
healthcare. Therefore, user-centred approaches, for
example incorporating qualitative methodologies or
‘A/B testing’ techniques, are necessary to overcome
potential barriers to engagement.30 These approaches
require a thorough investigation into the awareness,
comprehension and motivation for the use of novel
health interventions. The specific personal agency,
intervention content and quality as well as the ‘user
experience’, notably the interaction and perceived sup-
port, need to be studied and optimised for best uptake.
It is important to acknowledge that users perceived
several benefits of health chatbots, notably in relation
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Table 2. Sample characteristics and predictors of health chatbot acceptability.
Variable Total of the sample (%)
(%) of those ‘likely’ to use health chatbot within
12 months/Odds ratio [95%; CI]
Age [mean, SD] [30, 12]
Below 25 years 113 (53) (89)/2.07 [0.87–4.93]
25 years and above 102 (47) (80)/Ref
Gender
Male 84 (39) (87)/1.36 [0.55–3.38]
Female 131 (61) (84)/Ref
Ethnicity
White 138 (64) (83)/0.49 [0.17–1.39]
Non-white 77 (36) (90)/Ref
Education
Below university degree 116 (54) (84)/0.79 [0.33–1.87]
University degree 99 (46) (86)/Ref
Perceived IT skills
Poor or moderate 51 (24) (72)/0.32 [0.13–0.78]*
Good or very good 164 (76) (89)/Ref
Health information seeking
Several times per year 103 (48) (83)/0.72 [0.31–1.70]
Every month or more often 112 (52) (87)/Ref
Health chatbot awareness
Yes 12 (6) Assumption not meta
No 203 (94)
Past health chatbot use
Yes 7 (3) Assumption not meta
No 202 (97)
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Table 2. Continued.
Variable Total of the sample (%)
(%) of those ‘likely’ to use health chatbot within
12 months/Odds ratio [95%; CI]
Perceived utility of health chatbots#
To seek general health information
Likely 168 (78) (98)/5.10 [3.08–8.43]*
Unlikely 24 (11) (8)/Ref
To seek information about medication
Likely 128 (60) (99)/3.21 [1.92–5.37]*
Unlikely 52 (24) (49)/Ref
To seek information about diseases
Likely 148 (69) (97)/2.97 [2.10-4.10]*
Unlikely 38 (18) (33)/Ref
To seek information about symptoms
Likely 144 (67) (98)/3.44 [2.25-5.24]*
Unlikely 28 (13) (28)/Ref
To seek results of medical tests
Likely 83 (39) (92)/1.42 [1.08-1.85]*
Unlikely 81 (38) (75)/Ref
To book a medical appointment
Likely 167 (78) (92)/1.88 [1.46-2.42]*
Unlikely 34 (16) (50)/Ref
To look for local medical services (e.g. pharmacy)
Likely 172 (80) (92)/2.25 [1.64-3.08]*
Unlikely 17 (8) (33)/Ref
To seek specialist advice (e.g. sexual health)
Likely 104 (48) (98)/2.69 [1.61-4.49]*
Unlikely 65 (30) (61)/Ref
Beliefs associated with chatbot acceptability#
Worried about health
Agree 107 (50) (81)/0.94 [0.74-1.19]




Variable Total of the sample (%)
(%) of those ‘likely’ to use health chatbot within
12 months/Odds ratio [95%; CI]
Worried about privacy using a health chatbot
Agree 100 (47) (93)/1.42 [1.08-1.86]*
Disagree 71 (33) (77)/Ref
Worried about the security of information
Agree 100 (47) (93)/1.36 [1.02-1.81]*
Disagree 71 (33) (80)/Ref
Confident in finding accurate health information online
Agree 104 (48) (87)/1.31 [1.03-1.67]*
Disagree 50 (23) (70)/Ref
Confident in identifying own health symptoms
Agree 146 (68) (88)/1.20 [0.90-1.60]
Disagree 32 (15) (78)/Ref
Comfortable with outlining symptoms to a chatbot
Agree 131 (61) (91)/1.46 [1.07-1.99]*
Disagree 26 (12) (68)/Ref
Prefer to talk face to face with a doctor about health
Agree 158 (73) (83)/Assumption not meta
Disagree 19 (9) (100)
I don’t like talking to computers
Agree 64 (30) (77)/0.77 [0.60-0.99]*
Disagree 103 (48) (90)/Ref
It would be strange to talk to a chatbot about health
Agree 88 (41) (76)/0.72 [0.54-0.97]*
Disagree 68 (32) (93)/Ref
Health chatbot could help to make better decisions
Agree 65 (30) (100)/Assumption not meta
Disagree 42 (19) (62)
(continued)
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to anonymity, convenience and faster access to relevant
information. This is in line with previous research
showing that users might be as likely to disclose emo-
tional and factual information to a chatbot as they do
to a human partner.31 The perceived understanding,
disclosure intimacy and cognitive reappraisal were sim-
ilar in conversations conducted with chatbots and
humans, indicating that people psychologically
engage with chatbots as they do with people. The per-
ceived anonymity was noted by a few participants in
sexual health and mental health settings, although the
preferences for particular chatbot use in healthcare set-
tings needs to be explored further. Our analysis also
supports the findings from a qualitative study exploring
user expectations of chatbots in terms of their under-
standing and preferences.32 Users are generally unclear
about what chatbots can do, although they foresee this
technology as improving their experience by providing
immediate access to relevant and valuable information.
It was also shown that users saw the lack of judgement
as a unique aspect of this technology, although it was
noted that building rapport with a chatbot would
require trust and meaningful interactions. These moti-
vations for the use of chatbots need to be explored in
more detail in order to understand how this technology
could be safely incorporated into healthcare.
The present study had a number of methodological
issues. The use of mixed methods allowed new concepts
to be tested in the online survey, as the qualitative anal-
ysis of views on AI-led chatbots fed into the quantitative
arm of the study. In addition, the demonstration of the
popular chatbot and the opportunity for participants to
Table 2. Continued.
Variable Total of the sample (%)
(%) of those ‘likely’ to use health chatbot within
12 months/Odds ratio [95%; CI]
Would trust advice from a health chatbot
Agree 59 (27) (98)/1.92 [1.13-3.25]*
Disagree 54 (25) (78)/Ref
A health chatbot is a good idea
Agree 139 (65) (93)/2.71 [1.77-4.16]*
Disagree 13 (6) (20)/Ref
Willing to enter symptoms on an online form
Agree 136 (63) (91)/1.34 [0.95-1.86]
Disagree 24 (11) (76)/Ref
Curious how new technologies could improve health
Agree 172 (80) (88)/1.60 [1.15-2.21]*
Disagree 15 (7) (54)/Ref
Reliable and accurate information is important
Agree 199 (93) (85)/Assumption not meta
Disagree 4 (2) (0)
Only seek a doctor if I have a health problem
Agree 141 (66) (84)/0.81 [0.55-1.19]
Disagree 33 (15) (92)/Ref
*Significant at p<0.05; SD: standard deviation; CI: confidence intervals; #Neutral values removed for the binary regression analysis; Ref: reference category
for binary regression; aStatistical assumptions required to perform binary logistic regression with a single categorical predictor were not met.
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directly interact with it likely strengthen the validity of
the findings, as the explored views were not purely hypo-
thetical but based on experience during the study. The
qualitative sub-study also informed the development of
the exploratory survey, increasing its reliability, although
a further investigation into the development of measure-
ment tool is needed. Nevertheless, the survey responses
were mainly drawn from students and internet users, in
particular, a young and educated cohort that might not
be representative of the population that might be asked
to use health chatbots. It is likely that these answers are
more typical of people who are relatively experienced
with digital technologies. User ‘perceived IT skill’ was
a correlate of chatbot acceptability; thus future studies
need to assess the willingness to use these technologies in
clinical and community-based populations. A perspective
on patient acceptability of chatbots in those who experi-
ence acute and chronic conditions would enhance the
understanding of the feasibility of this intervention
within healthcare systems. In addition, the digital snow-
ball sampling method through social media, as used in
the present study, is likely to compromise the general-
isability of the findings if participants were selected
based on comparable characteristics. Thus, subsequent
assessments of chatbot acceptability should employ
robust methodological design able to capture diverse
views representative of potential healthcare users. It
would also be useful to examine the acceptability of spe-
cialist chatbots that serve a particular population or in
relation to a specific condition, as well as general chat-
bots used as a triage tool. Various designs of chatbots,
notably when the health information is stored and
retrieved or when chatbots are fully conversational,
could also affect acceptability and engagement.
There are several implications of this study. AI inter-
vention designers need to include opinions of users and
health professionals to maximise engagement and reten-
tion. No AI-led health chatbot should be implemented
without rigorous piloting that can address patients’ con-
cerns and remove any potential barriers. As a large
number of participants reported the preference for
face-to-face interaction, health chatbots should be a sup-
plementary service rather than a replacement of the pro-
fessional health force. While for some users they might
be perceived as a reduction in the quality of care, others
might see chatbots as an improvement, notably in over-
coming ‘shameful’ issues. Thus, their mechanism of
action and clinical effectiveness as an intervention
should be clearly and transparently communicated to
all users. Intervention designers should reassure users
of the human dimensions of AI systems that are devel-
oped to improve health and well-being in order to
increase the acceptability of these services.
This study has identified the concept of ‘AI hesitan-
cy’. As outlined, concerned about accuracy, cyber-
security, lack of empathy and technological maturity
were reported as potential factors associated with the
delay in acceptability or refusal. The construct of ‘hes-
itancy’ has been applied in various acceptability stud-
ies, notably in vaccinations, mainly referred to the level
of confidence, complacency and convenience.33
Although the constructs from the vaccine hesitancy
model could potentially overlap with AI hesitancy,
future research is needed to further define and opera-
tionalise this concept in order to have a precise under-
standing of motivations for patient engagement with
AI systems. As there is a substantial investment in
the development of AI in healthcare, purely driven by
the need for cost-effectiveness, it is essential to produce
a theory contributing to its design.
In conclusion, as the application of AI chatbot serv-
ices in healthcare is becoming more apparent, service
users’ motivation, uptake and engagement need to be
evaluated to maximise the benefits from these technol-
ogies. At present, we identified that many are receptive
to health chatbots, but a substantial number may feel
hesitant to use AI modules. Intervention designers need
to apply user-centred and theory-based approaches in
order to address user concerns and develop effective
and ethical services, capable of reducing the gap in
health and well-being. Future studies are required to
explore how health chatbots could be used in preven-
tative medicine and healthcare utilisation, notably by
allowing patients to engage with their health.
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